CN Stock MarketDetailed Quotes

Shanghai Kaibao Pharmaceutical (300039)

Watchlist
  • 5.98
  • -0.10-1.64%
Noon Break Apr 9 11:30 CST
6.26BMarket Cap18.12P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Kaibao Pharmaceutical (300039) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-26.95%819.03M
-27.08%604.66M
-15.74%400.64M
-7.57%1.47B
-2.87%1.12B
-2.03%829.15M
3.51%475.5M
42.47%1.59B
44.29%1.15B
56.68%846.35M
Operating revenue
-26.95%819.03M
-27.08%604.66M
-15.74%400.64M
-7.57%1.47B
-2.87%1.12B
-2.03%829.15M
3.51%475.5M
42.47%1.59B
44.29%1.15B
56.68%846.35M
Other operating revenue
----
549.12%942.74K
----
-37.25%1.9M
----
-84.56%145.23K
----
34.59%3.03M
----
-32.59%940.74K
Total operating cost
-29.06%621.97M
-28.99%470.62M
-20.25%299.42M
-13.61%1.07B
-5.47%876.74M
-3.74%662.73M
3.00%375.46M
39.78%1.24B
40.52%927.49M
55.20%688.47M
Operating cost
-24.77%157.73M
-25.24%114.24M
-18.28%72.31M
-12.71%272.76M
-12.91%209.65M
-15.53%152.82M
-1.15%88.49M
26.22%312.48M
39.85%240.74M
47.75%180.92M
Operating tax surcharges
-21.15%12.39M
-30.58%8.59M
-29.26%5.06M
-4.85%22.76M
-9.66%15.71M
-5.93%12.37M
0.16%7.15M
41.44%23.92M
51.79%17.39M
60.92%13.16M
Operating expense
-28.38%367.4M
-32.03%271.32M
-23.64%179.99M
-16.92%645.63M
-9.23%512.98M
-3.66%399.2M
-0.31%235.72M
40.19%777.07M
31.64%565.18M
49.51%414.37M
Administration expense
-28.04%47.31M
-9.73%37.35M
2.52%21.55M
0.50%81.47M
16.55%65.74M
6.59%41.37M
29.33%21.02M
38.40%81.06M
43.82%56.41M
47.57%38.81M
Financial expense
11.83%-26.11M
19.35%-15.28M
19.35%-7.51M
-1.80%-50.37M
-2.29%-29.61M
-4.10%-18.95M
-4.19%-9.31M
-16.33%-49.48M
-2.60%-28.95M
-18.16%-18.2M
-Interest expense (Financial expense)
427.51%77.55K
--44.59K
--22.05K
--37K
--14.7K
----
----
----
----
----
-Interest Income (Financial expense)
11.72%-26.24M
19.18%-15.36M
19.17%-7.55M
-1.85%-50.52M
-2.38%-29.72M
-4.14%-19.01M
-4.29%-9.34M
-16.26%-49.6M
-2.59%-29.03M
-18.09%-18.25M
Research and development
-38.14%63.26M
-28.34%54.41M
-13.49%28.02M
4.09%99.79M
33.29%102.27M
27.78%75.93M
34.50%32.38M
81.01%95.87M
112.59%76.73M
138.38%59.42M
Credit Impairment Loss
-12.93%5.18M
18.89%5.03M
-659.42%-879.57K
-18.99%4.32M
33.33%5.95M
403.80%4.23M
98.24%-115.82K
178.37%5.33M
7,105.53%4.46M
-205.95%-1.39M
Asset Impairment Loss
10,649.24%182.85K
10,599.13%181.99K
----
98.39%-197.17K
-98.78%1.7K
-99.61%1.7K
-99.52%1.7K
-143.16%-12.24M
-63.98%139.74K
-1.29%432.3K
Other net revenue
96.33%23.81M
292.89%10.91M
92.14%2.11M
23.94%36.98M
0.94%12.13M
-53.77%2.78M
0.18%1.1M
1,201.90%29.84M
176.24%12.01M
59.57%6.01M
Fair value change income
97.13%-103.82K
48.82%-3.64M
-63.36%-2.89M
261.91%1.1M
-1,093.76%-3.62M
-563.04%-7.11M
-150.14%-1.77M
49.41%-678.31K
105.97%363.83K
159.29%1.53M
Invest income
217.78%14.91M
168.70%6.58M
270.64%4.89M
24.09%13.98M
41.05%4.69M
-17.15%2.45M
-39.21%1.32M
314.66%11.27M
-1.00%3.33M
163.22%2.95M
-Including: Investment income associates
----
----
----
----
----
----
----
49.18%-4.55M
----
----
Asset deal income
491.35%46.63K
1,671.51%187.25K
83.43%-1.97K
-24.09%-256.43K
---11.92K
---11.92K
---11.92K
-18.61%-206.64K
----
----
Other revenue
-29.73%3.59M
-20.02%2.57M
-40.90%988.65K
-31.58%18.04M
37.34%5.11M
29.60%3.21M
3.77%1.67M
65.94%26.37M
-44.01%3.72M
-28.95%2.48M
Operating profit
-13.93%220.87M
-14.33%144.94M
2.17%103.33M
14.44%438.25M
7.44%256.62M
3.24%169.19M
5.39%101.14M
67.69%382.96M
65.51%238.86M
63.32%163.89M
Add:Non operating Income
1,703.44%36.54K
1,509.60%29.92K
-33.10%888.09
-65.52%373.37K
-96.02%2.03K
123.94%1.86K
--1.33K
2,033.17%1.08M
96.83%50.93K
-96.72%830
Less:Non operating expense
251.73%540.36K
767.03%433.52K
--28.98K
774.05%4.44M
-36.24%153.63K
-64.06%50K
----
-77.18%508.01K
-59.73%240.95K
-49.23%139.11K
Total profit
-14.08%220.36M
-14.55%144.54M
2.14%103.3M
13.21%434.18M
7.46%256.47M
3.30%169.15M
5.50%101.14M
69.56%383.53M
66.03%238.67M
63.59%163.75M
Less:Income tax cost
-15.41%33.69M
-16.15%22.84M
49.23%19.16M
4.66%59.27M
-7.01%39.83M
-4.98%27.24M
-18.46%12.84M
56.86%56.63M
66.66%42.84M
60.85%28.67M
Net profit
-13.83%186.67M
-14.24%121.7M
-4.71%84.14M
14.69%374.91M
10.62%216.64M
5.05%141.9M
10.21%88.3M
71.98%326.9M
65.90%195.83M
64.18%135.08M
Net profit from continuing operation
-13.83%186.67M
-14.24%121.7M
-4.71%84.14M
14.69%374.91M
10.62%216.64M
5.05%141.9M
10.21%88.3M
71.98%326.9M
65.90%195.83M
64.18%135.08M
Less:Minority Profit
14.16%-369.71K
-8.74%-256.29K
4.80%-152.11K
31.07%-670.21K
-47.19%-430.68K
-13.08%-235.68K
-163.11%-159.79K
-35.09%-972.31K
48.52%-292.59K
58.65%-208.42K
Net profit of parent company owners
-13.83%187.04M
-14.20%121.95M
-4.71%84.29M
14.55%375.58M
10.68%217.07M
5.07%142.14M
10.33%88.46M
71.84%327.87M
65.35%196.12M
63.44%135.29M
Earning per share
Basic earning per share
-13.83%0.1788
-14.20%0.1166
-4.73%0.0806
14.55%0.3591
10.67%0.2075
5.10%0.1359
10.30%0.0846
71.88%0.3135
65.34%0.1875
63.46%0.1293
Diluted earning per share
-13.83%0.1788
-14.20%0.1166
-4.73%0.0806
14.55%0.3591
10.67%0.2075
5.10%0.1359
10.30%0.0846
71.88%0.3135
65.34%0.1875
63.46%0.1293
Other composite income
195.77%277.74M
125.75%144.05M
106.52%22.26M
-4,735.88%-201.84M
-294.20%-290M
-1,094.68%-559.4M
-224.75%-341.46M
-99.14%4.35M
-112.57%-73.57M
-95.80%56.24M
Other composite income of parent company owners
195.77%277.74M
125.75%144.05M
106.52%22.26M
-4,735.88%-201.84M
-294.20%-290M
-1,094.68%-559.4M
-224.75%-341.46M
-99.14%4.35M
-112.57%-73.57M
-95.80%56.24M
Total composite income
733.05%464.41M
163.65%265.74M
142.03%106.4M
-47.75%173.07M
-160.00%-73.36M
-318.22%-417.5M
-171.55%-253.16M
-52.58%331.25M
-82.62%122.26M
-86.53%191.32M
Total composite income of parent company owners
737.30%464.78M
163.75%266M
142.11%106.55M
-47.70%173.74M
-159.51%-72.93M
-317.86%-417.26M
-171.49%-253M
-52.49%332.22M
-82.59%122.56M
-86.52%191.53M
Total composite income of minority owners
14.16%-369.71K
-8.74%-256.29K
4.80%-152.11K
31.07%-670.21K
-47.19%-430.68K
-13.08%-235.68K
-163.11%-159.79K
-35.09%-972.31K
48.52%-292.59K
58.65%-208.42K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -26.95%819.03M-27.08%604.66M-15.74%400.64M-7.57%1.47B-2.87%1.12B-2.03%829.15M3.51%475.5M42.47%1.59B44.29%1.15B56.68%846.35M
Operating revenue -26.95%819.03M-27.08%604.66M-15.74%400.64M-7.57%1.47B-2.87%1.12B-2.03%829.15M3.51%475.5M42.47%1.59B44.29%1.15B56.68%846.35M
Other operating revenue ----549.12%942.74K-----37.25%1.9M-----84.56%145.23K----34.59%3.03M-----32.59%940.74K
Total operating cost -29.06%621.97M-28.99%470.62M-20.25%299.42M-13.61%1.07B-5.47%876.74M-3.74%662.73M3.00%375.46M39.78%1.24B40.52%927.49M55.20%688.47M
Operating cost -24.77%157.73M-25.24%114.24M-18.28%72.31M-12.71%272.76M-12.91%209.65M-15.53%152.82M-1.15%88.49M26.22%312.48M39.85%240.74M47.75%180.92M
Operating tax surcharges -21.15%12.39M-30.58%8.59M-29.26%5.06M-4.85%22.76M-9.66%15.71M-5.93%12.37M0.16%7.15M41.44%23.92M51.79%17.39M60.92%13.16M
Operating expense -28.38%367.4M-32.03%271.32M-23.64%179.99M-16.92%645.63M-9.23%512.98M-3.66%399.2M-0.31%235.72M40.19%777.07M31.64%565.18M49.51%414.37M
Administration expense -28.04%47.31M-9.73%37.35M2.52%21.55M0.50%81.47M16.55%65.74M6.59%41.37M29.33%21.02M38.40%81.06M43.82%56.41M47.57%38.81M
Financial expense 11.83%-26.11M19.35%-15.28M19.35%-7.51M-1.80%-50.37M-2.29%-29.61M-4.10%-18.95M-4.19%-9.31M-16.33%-49.48M-2.60%-28.95M-18.16%-18.2M
-Interest expense (Financial expense) 427.51%77.55K--44.59K--22.05K--37K--14.7K--------------------
-Interest Income (Financial expense) 11.72%-26.24M19.18%-15.36M19.17%-7.55M-1.85%-50.52M-2.38%-29.72M-4.14%-19.01M-4.29%-9.34M-16.26%-49.6M-2.59%-29.03M-18.09%-18.25M
Research and development -38.14%63.26M-28.34%54.41M-13.49%28.02M4.09%99.79M33.29%102.27M27.78%75.93M34.50%32.38M81.01%95.87M112.59%76.73M138.38%59.42M
Credit Impairment Loss -12.93%5.18M18.89%5.03M-659.42%-879.57K-18.99%4.32M33.33%5.95M403.80%4.23M98.24%-115.82K178.37%5.33M7,105.53%4.46M-205.95%-1.39M
Asset Impairment Loss 10,649.24%182.85K10,599.13%181.99K----98.39%-197.17K-98.78%1.7K-99.61%1.7K-99.52%1.7K-143.16%-12.24M-63.98%139.74K-1.29%432.3K
Other net revenue 96.33%23.81M292.89%10.91M92.14%2.11M23.94%36.98M0.94%12.13M-53.77%2.78M0.18%1.1M1,201.90%29.84M176.24%12.01M59.57%6.01M
Fair value change income 97.13%-103.82K48.82%-3.64M-63.36%-2.89M261.91%1.1M-1,093.76%-3.62M-563.04%-7.11M-150.14%-1.77M49.41%-678.31K105.97%363.83K159.29%1.53M
Invest income 217.78%14.91M168.70%6.58M270.64%4.89M24.09%13.98M41.05%4.69M-17.15%2.45M-39.21%1.32M314.66%11.27M-1.00%3.33M163.22%2.95M
-Including: Investment income associates ----------------------------49.18%-4.55M--------
Asset deal income 491.35%46.63K1,671.51%187.25K83.43%-1.97K-24.09%-256.43K---11.92K---11.92K---11.92K-18.61%-206.64K--------
Other revenue -29.73%3.59M-20.02%2.57M-40.90%988.65K-31.58%18.04M37.34%5.11M29.60%3.21M3.77%1.67M65.94%26.37M-44.01%3.72M-28.95%2.48M
Operating profit -13.93%220.87M-14.33%144.94M2.17%103.33M14.44%438.25M7.44%256.62M3.24%169.19M5.39%101.14M67.69%382.96M65.51%238.86M63.32%163.89M
Add:Non operating Income 1,703.44%36.54K1,509.60%29.92K-33.10%888.09-65.52%373.37K-96.02%2.03K123.94%1.86K--1.33K2,033.17%1.08M96.83%50.93K-96.72%830
Less:Non operating expense 251.73%540.36K767.03%433.52K--28.98K774.05%4.44M-36.24%153.63K-64.06%50K-----77.18%508.01K-59.73%240.95K-49.23%139.11K
Total profit -14.08%220.36M-14.55%144.54M2.14%103.3M13.21%434.18M7.46%256.47M3.30%169.15M5.50%101.14M69.56%383.53M66.03%238.67M63.59%163.75M
Less:Income tax cost -15.41%33.69M-16.15%22.84M49.23%19.16M4.66%59.27M-7.01%39.83M-4.98%27.24M-18.46%12.84M56.86%56.63M66.66%42.84M60.85%28.67M
Net profit -13.83%186.67M-14.24%121.7M-4.71%84.14M14.69%374.91M10.62%216.64M5.05%141.9M10.21%88.3M71.98%326.9M65.90%195.83M64.18%135.08M
Net profit from continuing operation -13.83%186.67M-14.24%121.7M-4.71%84.14M14.69%374.91M10.62%216.64M5.05%141.9M10.21%88.3M71.98%326.9M65.90%195.83M64.18%135.08M
Less:Minority Profit 14.16%-369.71K-8.74%-256.29K4.80%-152.11K31.07%-670.21K-47.19%-430.68K-13.08%-235.68K-163.11%-159.79K-35.09%-972.31K48.52%-292.59K58.65%-208.42K
Net profit of parent company owners -13.83%187.04M-14.20%121.95M-4.71%84.29M14.55%375.58M10.68%217.07M5.07%142.14M10.33%88.46M71.84%327.87M65.35%196.12M63.44%135.29M
Earning per share
Basic earning per share -13.83%0.1788-14.20%0.1166-4.73%0.080614.55%0.359110.67%0.20755.10%0.135910.30%0.084671.88%0.313565.34%0.187563.46%0.1293
Diluted earning per share -13.83%0.1788-14.20%0.1166-4.73%0.080614.55%0.359110.67%0.20755.10%0.135910.30%0.084671.88%0.313565.34%0.187563.46%0.1293
Other composite income 195.77%277.74M125.75%144.05M106.52%22.26M-4,735.88%-201.84M-294.20%-290M-1,094.68%-559.4M-224.75%-341.46M-99.14%4.35M-112.57%-73.57M-95.80%56.24M
Other composite income of parent company owners 195.77%277.74M125.75%144.05M106.52%22.26M-4,735.88%-201.84M-294.20%-290M-1,094.68%-559.4M-224.75%-341.46M-99.14%4.35M-112.57%-73.57M-95.80%56.24M
Total composite income 733.05%464.41M163.65%265.74M142.03%106.4M-47.75%173.07M-160.00%-73.36M-318.22%-417.5M-171.55%-253.16M-52.58%331.25M-82.62%122.26M-86.53%191.32M
Total composite income of parent company owners 737.30%464.78M163.75%266M142.11%106.55M-47.70%173.74M-159.51%-72.93M-317.86%-417.26M-171.49%-253M-52.49%332.22M-82.59%122.56M-86.52%191.53M
Total composite income of minority owners 14.16%-369.71K-8.74%-256.29K4.80%-152.11K31.07%-670.21K-47.19%-430.68K-13.08%-235.68K-163.11%-159.79K-35.09%-972.31K48.52%-292.59K58.65%-208.42K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +0.56%
Sample Name
Sample Code
 -3.56%
Sample Name
Sample Code
 -6.21%
4
CHINA OILFIELD
02883
-6.77%
5
KUNLUN ENERGY
00135
-10.44%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.31%
Sample Name
Sample Code
 +13.61%
Sample Name
Sample Code
 +8.13%
4
Hangzhou Shunwang Technology
300113
-4.73%
5
Rockchip Electronics
603893
-9.01%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -